SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-128983
Filing Date
2021-04-23
Accepted
2021-04-23 16:05:54
Documents
4
Period of Report
2021-06-11

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d122933ddef14a.htm DEF 14A 313175
2 GRAPHIC g122933g01a20.jpg GRAPHIC 188100
3 GRAPHIC g122933g02a33.jpg GRAPHIC 231295
4 GRAPHIC g122933g03a66.jpg GRAPHIC 121837
  Complete submission text file 0001193125-21-128983.txt   1060079
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36644 | Film No.: 21849738
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences